210 related articles for article (PubMed ID: 27036855)
1. Cyp1b1 affects external control of mouse hepatocytes, fatty acid homeostasis and signaling involving HNF4α and PPARα.
Bushkofsky JR; Maguire M; Larsen MC; Fong YH; Jefcoate CR
Arch Biochem Biophys; 2016 May; 597():30-47. PubMed ID: 27036855
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 1B1: An unexpected modulator of liver fatty acid homeostasis.
Larsen MC; Bushkofsky JR; Gorman T; Adhami V; Mukhtar H; Wang S; Reeder SB; Sheibani N; Jefcoate CR
Arch Biochem Biophys; 2015 Apr; 571():21-39. PubMed ID: 25703193
[TBL] [Abstract][Full Text] [Related]
3. Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARα, SCD1, and osteopontin.
Rojas IY; Moyer BJ; Ringelberg CS; Tomlinson CR
Int J Obes (Lond); 2020 Apr; 44(4):948-963. PubMed ID: 31911663
[TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
5. PPARα/HNF4α interplay on diversified responsive elements. Relevance in the regulation of liver peroxisomal fatty acid catabolism.
Chamouton J; Latruffe N
Curr Drug Metab; 2012 Dec; 13(10):1436-53. PubMed ID: 22978398
[TBL] [Abstract][Full Text] [Related]
6. Lipidomics reveals a link between CYP1B1 and SCD1 in promoting obesity.
Li F; Jiang C; Larsen MC; Bushkofsky J; Krausz KW; Wang T; Jefcoate CR; Gonzalez FJ
J Proteome Res; 2014 May; 13(5):2679-87. PubMed ID: 24684199
[TBL] [Abstract][Full Text] [Related]
7. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
[TBL] [Abstract][Full Text] [Related]
8. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.
Huang J; Jia Y; Fu T; Viswakarma N; Bai L; Rao MS; Zhu Y; Borensztajn J; Reddy JK
FASEB J; 2012 Feb; 26(2):628-38. PubMed ID: 22009939
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet.
Lu H; Lei X; Winkler R; John S; Kumar D; Li W; Alnouti Y
Lipids Health Dis; 2022 May; 21(1):46. PubMed ID: 35614477
[TBL] [Abstract][Full Text] [Related]
10. Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasis.
Konstandi M; Shah YM; Matsubara T; Gonzalez FJ
PLoS One; 2013; 8(8):e70675. PubMed ID: 23967086
[TBL] [Abstract][Full Text] [Related]
11. Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Nemani KV; Trask HW; Ringelberg CS; Gimi B; Demidenko E; Tomlinson CR
Nutr Res; 2017 Aug; 44():38-50. PubMed ID: 28821316
[TBL] [Abstract][Full Text] [Related]
12. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
[TBL] [Abstract][Full Text] [Related]
14. NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease.
Li Y; Chen M; Zhou Y; Tang C; Zhang W; Zhong Y; Chen Y; Zhou H; Sheng L
Theranostics; 2020; 10(8):3579-3593. PubMed ID: 32206109
[No Abstract] [Full Text] [Related]
15. Cyp1b1 deletion and retinol deficiency coordinately suppress mouse liver lipogenic genes and hepcidin expression during post-natal development.
Maguire M; Larsen MC; Foong YH; Tanumihardjo S; Jefcoate CR
Mol Cell Endocrinol; 2017 Oct; 454():50-68. PubMed ID: 28583802
[TBL] [Abstract][Full Text] [Related]
16. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
17. Small heterodimer partner (SHP) deficiency protects myocardia from lipid accumulation in high fat diet-fed mice.
Ohn JH; Hwang JY; Moon MK; Ahn HY; Kim HH; Koo YD; Kim KI; Chang HJ; Lee HS; Jang HC; Park YJ
PLoS One; 2017; 12(10):e0186021. PubMed ID: 29016649
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
[TBL] [Abstract][Full Text] [Related]
19. WY-14643 Regulates CYP1B1 Expression through Peroxisome Proliferator-Activated Receptor α-Mediated Signaling in Human Breast Cancer Cells.
Hwang YP; Won SS; Jin SW; Lee GH; Pham TH; Choi JH; Kang KW; Jeong HG
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775380
[TBL] [Abstract][Full Text] [Related]
20. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.
Finck BN; Gropler MC; Chen Z; Leone TC; Croce MA; Harris TE; Lawrence JC; Kelly DP
Cell Metab; 2006 Sep; 4(3):199-210. PubMed ID: 16950137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
